http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120124145-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L31-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120124145-A |
| titleOfInvention | Composition for inhibiting multi-drug resistance comprising the extract of Bokryeong as an active ingredient |
| abstract | The present invention provides a pharmaceutical composition for inhibiting multi-drug resistance, comprising as an active ingredient, Bokryeong extract having excellent multidrug resistance (MDR) inhibition. The composition of the present invention can overcome the anti-cancer drug resistance seen in multi-drug resistant cells resistant to anti-cancer drugs, and can be used as a pharmaceutically useful composition for inhibiting multi-drug resistance and as an anticancer adjuvant. |
| priorityDate | 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 137.